UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000010543
Receipt number R000012329
Scientific Title Comparison of metformin and vildagliptin in type 2 diabetes assessed by meal tolerance test
Date of disclosure of the study information 2013/04/22
Last modified on 2020/10/29 13:37:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparison of metformin and vildagliptin in type 2 diabetes assessed by meal tolerance test

Acronym

Comparison of metformin and vildagliptin in type 2 diabetes assessed by meal tolerance test

Scientific Title

Comparison of metformin and vildagliptin in type 2 diabetes assessed by meal tolerance test

Scientific Title:Acronym

Comparison of metformin and vildagliptin in type 2 diabetes assessed by meal tolerance test

Region

Japan


Condition

Condition

type 2 diabetes

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To compare metformin and vildagliptin for efficacy in type 2 diabetes

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Comparison of glucose variability between two treatments by Meal Tolerance Test

Key secondary outcomes

Comparison of serum C-peptide and glucagon levels between two treatments


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Hospitalized patients with type 2 diabetes under insulin therapy or oral diabetic agents treatment will be enrolled. Insulin secretion will be evaluated by glucagon test prior to the treatments for this study to exclude the subjects without enough capacity of insulin secretion (deltaCPR <1.0ng/ml). After fasting blood glucose is controlled to the range from 80mg/dl to 130mg/dl (during pre observation period), either metformin (1000mg/day) or vildagliptin (100mg/day) will be administered to each patient for 3 days followed by MTT (First period).Then, the drug will be switched to another one for next 3 days followed by MTT (Second period). Finally, the combination of two drugs will be administered for last three days followed by MTT (Third period)

metformin 1000mg/day->vildagliptin 100mg/day

Interventions/Control_2

vildagliptin 100mg/day->metformin 1000mg/day

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

Patients with type 2 diabetes who meet the following conditions:
(1)Age: younger than 75 years old, elder than 20 years old
(2)recent HbA1c : less than 12.0%

Key exclusion criteria

Patients who falls under any of the following conditions shall be excluded:
(1)Type 1 diabetes or type 2 diabetes with insulin-dependent condition
(2)severe renal and liver dysfunction
(3)unstable pre or proliferative diabetic retinopathy, severe neuropathy
(4)past history of the gastrointestinal tract or pancreas operation
(5)administered steroid drugs
(6)severe infection
(7)pregnant or planned pregnant in the near future
(8)ineligible for some other medical reasons judged by the investigator

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Akira
Middle name
Last name Kawashima

Organization

Naga Municipal Hospital

Division name

Department of Internal Medicine

Zip code

6496414

Address

1282 Uchita, Kinokawa City, 1282 Uchita, Kinokawa City, Wakayama 649-6414, Japan

TEL

0736-77-2019

Email

soumu@nagahp.jp


Public contact

Name of contact person

1st name Tetsushi
Middle name
Last name Nasu

Organization

Naga Municipal Hospital

Division name

Department of Internal Medicine

Zip code

649-6414

Address

1282 Uchita, Kinokawa City, Wakayama 649-6414, Japan

TEL

0736772019

Homepage URL


Email

soumu@nagahp.jp


Sponsor or person

Institute

Naga Municipal Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Naga Municipal Hospital

Address

1282 Uchita, Kinokawa City, Wakayama 649-6414, Japan

Tel

0736772019

Email

soumu@nagahp.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

公立那賀病院 内科 Department of Internal Medicine, Naga Municipal Hospital


Other administrative information

Date of disclosure of the study information

2013 Year 04 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2013 Year 04 Month 16 Day

Date of IRB

2013 Year 04 Month 16 Day

Anticipated trial start date

2013 Year 04 Month 22 Day

Last follow-up date

2013 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2013 Year 04 Month 19 Day

Last modified on

2020 Year 10 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012329


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name